Rankings
▼
Calendar
GUTS Q2 2023 Earnings — Fractyl Health, Inc. Common Stock Revenue & Financial Results | Market Cap Arena
GUTS
Fractyl Health, Inc. Common Stock
$35M
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$72,000
Gross Profit
$25,000
34.7% margin
Operating Income
-$12M
-16493.1% margin
Net Income
-$30M
-41988.9% margin
EPS (Diluted)
$-0.63
QoQ Revenue Growth
+1340.0%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$12M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$39M
Total Liabilities
$331M
Stockholders' Equity
-$293M
Cash & Equivalents
$28M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$72,000
$0
—
Gross Profit
$25,000
$0
—
Operating Income
-$12M
-$13M
+10.1%
Net Income
-$30M
-$12M
-146.5%
← FY 2023
All Quarters
Q3 2023 →